Clinical trial

Acarbose and Secondary Prevention After Coronary Stenting

NCT00221156

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE3

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2009-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glucose Metabolism Disordersunresolved

Coronary Artery Diseaseunresolved

Interventions

AcarboseDRUG · verified · RxNorm: acarbose

Sponsors & collaborators

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japanlead sponsor

Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japancollaborator

Kobe City General Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00221156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.